MKI67 and cancer: To determine whether anti-TIGIT impacted cell proliferation in the setting of CA sepsis, we measured the frequency of Ki-67+–proliferating T cells in the spleens of anti-TIGIT–treated CA septic mice versus PBS-treated CA septic mice.